Technical analysis of Rocket Pharmaceuticals, Inc. (RCKT): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Rocket Pharmaceuticals, Inc., operating alongside its affiliates, is an innovative biotechnology enterprise dedicated to pioneering gene therapies for rare and severely debilitating diseases. The company's active clinical pipeline features multiple promising programs.
Price Performance
| 1 month | +1.95% |
| 3 months | +1.64% |
| Year-to-date | -2.99% |
| 1 year | +12.38% |
| 3 years | -85.31% |
| 5 years | -90.04% |
52-Week Range
| 52-week High | $5.45 |
| 52-week Low | $2.53 |
| Avg Volume (90d) | 2.1M |
Technical Indicators
| SMA 50 | $3.53 |
| SMA 200 | $3.59 |
| Beta | 0.57 |
| 30-day Volatility (annualised) | 54.2% |
| Price vs SMA 50 | -3.7% |
| Price vs SMA 200 | -5.3% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $3.77 | |
| 2025-11 | $3.42 | -9.3% |
| 2025-12 | $3.51 | +2.6% |
| 2026-01 | $3.48 | -0.9% |
| 2026-02 | $5.01 | +44.0% |
| 2026-03 | $3.58 | -28.5% |
| 2026-04 | $3.48 | -2.8% |
| 2026-05 | $3.07 | -11.8% |
| 2026-06 | $3.42 | +11.4% |
| 2026-07 | $3.11 | -9.1% |
| 2026-08 | $3.72 | +19.6% |
| 2026-09 | $3.40 | -8.5% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $0.10 | $672M |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | |
| 2026-09-14 | | $898M |
| 2026-09-14 | $0.03 | $3M |
Price
| Price | $3.48 |
| Market Cap | $380M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 1.02 |
| EV / EBITDA | 20.89 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.07 |
| Current Ratio | 9.24 |